Research and Markets: Competitor Analysis: CD20 Antibodies - Rituximab ... Business Wire (press release) The present Competitive Intelligence Report about CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors provides a competitor evaluation in the field of recombinant antibodies targeting CD20 for treatment of B-cell mediated malignancies ... |
